Global mRNA Vaccine Market Research Report 2020

The global mRNA Vaccine market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.

This report focuses on mRNA Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall mRNA Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

    Standardization Of Cancer Treatment MRNA Vaccine

    Individualized Cancer Treatment MRNA Vaccine

    Infectious Disease Treatment MRNA Vaccine

    Infection Prevention MRNA Vaccine

    Infectious Disease

    Cancer

    Other

 Global mRNA Vaccine Market: Regional Analysis

The key regions covered in the mRNA Vaccine market report are:

North America

    U.S.

    Canada

Europe

    Germany

    France

    U.K.

    Italy

    Russia

Asia-Pacific

    China

    Japan

    South Korea

    India

    Australia

    Taiwan

    Indonesia

    Thailand

    Malaysia

    Philippines

    Vietnam

Latin America

    Mexico

    Brazil

    Argentina

Middle East & Africa

    Turkey

    Saudi Arabia

    U.A.E

Global mRNA Vaccine Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global mRNA Vaccine market include:

    Moderna Therapeutics

    CureVac

    Translate Bio

    BioNTech

    Sangamo Therapeutics

    Argos Therapeutics

    In-Cell-Art

    eTheRNA

    Ethris

    Tiba Biotechnology

Table of Contents

1.1 Product Overview and Scope of mRNA Vaccine

1.2 mRNA Vaccine Segment by Type

1.2.1 Global mRNA Vaccine Sales Growth Rate Comparison by Type (2021-2026)

1.2.2 Standardization Of Cancer Treatment MRNA Vaccine

1.2.3 Individualized Cancer Treatment MRNA Vaccine

1.2.4 Infectious Disease Treatment MRNA Vaccine

1.2.5 Infection Prevention MRNA Vaccine

1.3 mRNA Vaccine Segment by Application

1.3.1 mRNA Vaccine Sales Comparison by Application: 2020 VS 2026

1.3.2 Infectious Disease

1.3.3 Cancer

1.3.4 Other

1.4 Global mRNA Vaccine Market Size Estimates and Forecasts

1.4.1 Global mRNA Vaccine Revenue 2015-2026

1.4.2 Global mRNA Vaccine Sales 2015-2026

1.4.3 mRNA Vaccine Market Size by Region: 2020 Versus 2026

2.1 Global mRNA Vaccine Sales Market Share by Manufacturers (2015-2020)

2.2 Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020)

2.3 Global mRNA Vaccine Average Price by Manufacturers (2015-2020)

2.4 Manufacturers mRNA Vaccine Manufacturing Sites, Area Served, Product Type

2.5 mRNA Vaccine Market Competitive Situation and Trends

2.5.1 mRNA Vaccine Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

2.7 Primary Interviews with Key mRNA Vaccine Players (Opinion Leaders)

3.1 Global mRNA Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020

3.2 Global mRNA Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3.3 North America mRNA Vaccine Market Facts & Figures by Country

3.3.1 North America mRNA Vaccine Sales by Country

3.3.2 North America mRNA Vaccine Sales by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe mRNA Vaccine Market Facts & Figures by Country

3.4.1 Europe mRNA Vaccine Sales by Country

3.4.2 Europe mRNA Vaccine Sales by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific mRNA Vaccine Market Facts & Figures by Region

3.5.1 Asia Pacific mRNA Vaccine Sales by Region

3.5.2 Asia Pacific mRNA Vaccine Sales by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America mRNA Vaccine Market Facts & Figures by Country

3.6.1 Latin America mRNA Vaccine Sales by Country

3.6.2 Latin America mRNA Vaccine Sales by Country

3.6.3 Mexico

3.6.3 Brazil

3.6.3 Argentina

3.7 Middle East and Africa mRNA Vaccine Market Facts & Figures by Country

3.7.1 Middle East and Africa mRNA Vaccine Sales by Country

3.7.2 Middle East and Africa mRNA Vaccine Sales by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4.1 Global mRNA Vaccine Sales Market Share by Type (2015-2020)

4.2 Global mRNA Vaccine Revenue Market Share by Type (2015-2020)

4.3 Global mRNA Vaccine Price Market Share by Type (2015-2020)

4.4 Global mRNA Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global mRNA Vaccine Sales Market Share by Application (2015-2020)

5.2 Global mRNA Vaccine Revenue Market Share by Application (2015-2020)

5.3 Global mRNA Vaccine Price by Application (2015-2020)

6.1 Moderna Therapeutics

6.1.1 Corporation Information

6.1.2 Moderna Therapeutics Description, Business Overview and Total Revenue

6.1.3 Moderna Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.1.4 Moderna Therapeutics Products Offered

6.1.5 Moderna Therapeutics Recent Development

6.2 CureVac

6.2.1 CureVac mRNA Vaccine Production Sites and Area Served

6.2.2 CureVac Description, Business Overview and Total Revenue

6.2.3 CureVac mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.2.4 CureVac Products Offered

6.2.5 CureVac Recent Development

6.3 Translate Bio

6.3.1 Translate Bio mRNA Vaccine Production Sites and Area Served

6.3.2 Translate Bio Description, Business Overview and Total Revenue

6.3.3 Translate Bio mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.3.4 Translate Bio Products Offered

6.3.5 Translate Bio Recent Development

6.4 BioNTech

6.4.1 BioNTech mRNA Vaccine Production Sites and Area Served

6.4.2 BioNTech Description, Business Overview and Total Revenue

6.4.3 BioNTech mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.4.4 BioNTech Products Offered

6.4.5 BioNTech Recent Development

6.5 Sangamo Therapeutics

6.5.1 Sangamo Therapeutics mRNA Vaccine Production Sites and Area Served

6.5.2 Sangamo Therapeutics Description, Business Overview and Total Revenue

6.5.3 Sangamo Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.5.4 Sangamo Therapeutics Products Offered

6.5.5 Sangamo Therapeutics Recent Development

6.6 Argos Therapeutics

6.6.1 Argos Therapeutics mRNA Vaccine Production Sites and Area Served

6.6.2 Argos Therapeutics Description, Business Overview and Total Revenue

6.6.3 Argos Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.6.4 Argos Therapeutics Products Offered

6.6.5 Argos Therapeutics Recent Development

6.7 In-Cell-Art

6.6.1 In-Cell-Art mRNA Vaccine Production Sites and Area Served

6.6.2 In-Cell-Art Description, Business Overview and Total Revenue

6.6.3 In-Cell-Art mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.4.4 In-Cell-Art Products Offered

6.7.5 In-Cell-Art Recent Development

6.8 eTheRNA

6.8.1 eTheRNA mRNA Vaccine Production Sites and Area Served

6.8.2 eTheRNA Description, Business Overview and Total Revenue

6.8.3 eTheRNA mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.8.4 eTheRNA Products Offered

6.8.5 eTheRNA Recent Development

6.9 Ethris

6.9.1 Ethris mRNA Vaccine Production Sites and Area Served

6.9.2 Ethris Description, Business Overview and Total Revenue

6.9.3 Ethris mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.9.4 Ethris Products Offered

6.9.5 Ethris Recent Development

6.10 Tiba Biotechnology

6.10.1 Tiba Biotechnology mRNA Vaccine Production Sites and Area Served

6.10.2 Tiba Biotechnology Description, Business Overview and Total Revenue

6.10.3 Tiba Biotechnology mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.10.4 Tiba Biotechnology Products Offered

6.10.5 Tiba Biotechnology Recent Development

7.1 mRNA Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price Trend

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of mRNA Vaccine

7.4 mRNA Vaccine Industrial Chain Analysis

8.1 Marketing Channel

8.2 mRNA Vaccine Distributors List

8.3 mRNA Vaccine Customers

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

10.1 Global mRNA Vaccine Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of mRNA Vaccine by Type (2021-2026)

10.1.2 Global Forecasted Revenue of mRNA Vaccine by Type (2021-2026)

10.2 mRNA Vaccine Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of mRNA Vaccine by Application (2021-2026)

10.2.2 Global Forecasted Revenue of mRNA Vaccine by Application (2021-2026)

10.3 mRNA Vaccine Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of mRNA Vaccine by Region (2021-2026)

10.3.2 Global Forecasted Revenue of mRNA Vaccine by Region (2021-2026)

10.4 North America mRNA Vaccine Estimates and Projections (2021-2026)

10.5 Europe mRNA Vaccine Estimates and Projections (2021-2026)

10.6 Asia Pacific mRNA Vaccine Estimates and Projections (2021-2026)

10.7 Latin America mRNA Vaccine Estimates and Projections (2021-2026)

10.8 Middle East and Africa mRNA Vaccine Estimates and Projections (2021-2026)

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

    Table 1. Global mRNA Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026)

    Table 2. Global mRNA Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026

    Table 3. Global mRNA Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)

    Table 4. Global Key mRNA Vaccine Manufacturers Covered in This Study

    Table 5. Global mRNA Vaccine Sales (K Doses) by Manufacturers (2015-2020)

    Table 6. Global mRNA Vaccine Sales Share by Manufacturers (2015-2020)

    Table 7. Global mRNA Vaccine Revenue (Million USD) by Manufacturers (2015-2020)

    Table 8. Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020)

    Table 9. Global Market mRNA Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020)

    Table 10. Manufacturers mRNA Vaccine Sales Sites and Area Served

    Table 11. Manufacturers mRNA Vaccine Product Types

    Table 12. Global mRNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 13. Global mRNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine as of 2019)

    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 15. Main Points Interviewed from Key mRNA Vaccine Players

    Table 16. Global mRNA Vaccine Sales (K Doses) by Region (2015-2020)

    Table 17. Global mRNA Vaccine Sales Market Share by Region (2015-2020)

    Table 18. Global mRNA Vaccine Revenue (Million US$) by Region (2015-2020)

    Table 19. Global mRNA Vaccine Revenue Market Share by Region (2015-2020)

    Table 20. North America mRNA Vaccine Sales by Country (2015-2020) (K Doses)

    Table 21. North America mRNA Vaccine Sales Market Share by Country (2015-2020)

    Table 22. North America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 23. North America mRNA Vaccine Revenue Market Share by Country (2015-2020)

    Table 24. Europe mRNA Vaccine Sales by Country (2015-2020) (K Doses)

    Table 25. Europe mRNA Vaccine Sales Market Share by Country (2015-2020)

    Table 26. Europe mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 27. Europe mRNA Vaccine Revenue Market Share by Country (2015-2020)

    Table 28. Asia Pacific mRNA Vaccine Sales by Region (2015-2020) (K Doses)

    Table 29. Asia Pacific mRNA Vaccine Sales Market Share by Region (2015-2020)

    Table 30. Asia Pacific mRNA Vaccine Revenue by Region (2015-2020) (US$ Million)

    Table 31. Asia Pacific mRNA Vaccine Revenue Market Share by Region (2015-2020)

    Table 32. Latin America mRNA Vaccine Sales by Country (2015-2020) (K Doses)

    Table 33. Latin America mRNA Vaccine Sales Market Share by Country (2015-2020)

    Table 34. Latin America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 35. Latin America mRNA Vaccine Revenue Market Share by Country (2015-2020)

    Table 36. Middle East and Africa mRNA Vaccine Sales by Country (2015-2020) (K Doses)

    Table 37. Middle East and Africa mRNA Vaccine Sales Market Share by Country (2015-2020)

    Table 38. Middle East and Africa mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 39. Middle East and Africa mRNA Vaccine Revenue Market Share by Country (2015-2020)

    Table 40. Global mRNA Vaccine Sales (K Doses) by Type (2015-2020)

    Table 41. Global mRNA Vaccine Sales Share by Type (2015-2020)

    Table 42. Global mRNA Vaccine Revenue (Million US$) by Type (2015-2020)

    Table 43. Global mRNA Vaccine Revenue Share by Type (2015-2020)

    Table 44. Global mRNA Vaccine Price (USD/Dose) by Type (2015-2020)

    Table 45. Global mRNA Vaccine Sales (K Doses) by Application (2015-2020)

    Table 46. Global mRNA Vaccine Sales Market Share by Application (2015-2020)

    Table 47. Global mRNA Vaccine Sales Growth Rate by Application (2015-2020)

    Table 48. Moderna Therapeutics mRNA Vaccine Corporation Information

    Table 49. Moderna Therapeutics Description and Business Overview

    Table 50. Moderna Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 51. Moderna Therapeutics Main Product

    Table 52. Moderna Therapeutics Recent Development

    Table 53. CureVac mRNA Vaccine Corporation Information

    Table 54. CureVac Corporation Information

    Table 55. CureVac mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 56. CureVac Main Product

    Table 57. CureVac Recent Development

    Table 58. Translate Bio mRNA Vaccine Corporation Information

    Table 59. Translate Bio Corporation Information

    Table 60. Translate Bio mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 61. Translate Bio Main Product

    Table 62. Translate Bio Recent Development

    Table 63. BioNTech mRNA Vaccine Corporation Information

    Table 64. BioNTech Corporation Information

    Table 65. BioNTech mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 66. BioNTech Main Product

    Table 67. BioNTech Recent Development

    Table 68. Sangamo Therapeutics mRNA Vaccine Corporation Information

    Table 69. Sangamo Therapeutics Corporation Information

    Table 70. Sangamo Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 71. Sangamo Therapeutics Main Product

    Table 72. Sangamo Therapeutics Recent Development

    Table 73. Argos Therapeutics mRNA Vaccine Corporation Information

    Table 74. Argos Therapeutics Corporation Information

    Table 75. Argos Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 76. Argos Therapeutics Main Product

    Table 77. Argos Therapeutics Recent Development

    Table 78. In-Cell-Art mRNA Vaccine Corporation Information

    Table 79. In-Cell-Art Corporation Information

    Table 80. In-Cell-Art mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 81. In-Cell-Art Main Product

    Table 82. In-Cell-Art Recent Development

    Table 83. eTheRNA mRNA Vaccine Corporation Information

    Table 84. eTheRNA Corporation Information

    Table 85. eTheRNA mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 86. eTheRNA Main Product

    Table 87. eTheRNA Recent Development

    Table 88. Ethris mRNA Vaccine Corporation Information

    Table 89. Ethris Corporation Information

    Table 90. Ethris mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 91. Ethris Main Product

    Table 92. Ethris Recent Development

    Table 93. Tiba Biotechnology mRNA Vaccine Corporation Information

    Table 94. Tiba Biotechnology Corporation Information

    Table 95. Tiba Biotechnology mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 96. Tiba Biotechnology Main Product

    Table 97. Tiba Biotechnology Recent Development

    Table 98. Sales Base and Market Concentration Rate of Raw Material

    Table 99. Key Suppliers of Raw Materials

    Table 100. mRNA Vaccine Distributors List

    Table 101. mRNA Vaccine Customers List

    Table 102. Market Key Trends

    Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 104. Key Challenges

    Table 105. Global mRNA Vaccine Sales (K Doses) Forecast by Type (2021-2026)

    Table 106. Global mRNA Vaccine Sales Market Share Forecast by Type (2021-2026)

    Table 107. Global mRNA Vaccine Revenue (Million US$) Forecast by Type (2021-2026)

    Table 108. Global mRNA Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)

    Table 109. Global mRNA Vaccine Sales (K Doses) Forecast by Application (2021-2026)

    Table 110. Global mRNA Vaccine Revenue (Million US$) Forecast by Application (2021-2026)

    Table 111. Global mRNA Vaccine Sales (K Doses) Forecast by Region (2021-2026)

    Table 112. Global mRNA Vaccine Sales Market Share Forecast by Region (2021-2026)

    Table 113. Global mRNA Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 114. Global mRNA Vaccine Revenue Market Share Forecast by Region (2021-2026)

    Table 115. Research Programs/Design for This Report

    Table 116. Key Data Information from Secondary Sources

    Table 117. Key Data Information from Primary Sources

List of Figures

    Figure 1. Picture of mRNA Vaccine

    Figure 2. Global mRNA Vaccine Sales Market Share by Type: 2020 VS 2026

    Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Product Picture

    Figure 4. Individualized Cancer Treatment MRNA Vaccine Product Picture

    Figure 5. Infectious Disease Treatment MRNA Vaccine Product Picture

    Figure 6. Infection Prevention MRNA Vaccine Product Picture

    Figure 7. Global mRNA Vaccine Consumption Market Share by Application: 2020 VS 2026

    Figure 8. Infectious Disease

    Figure 9. Cancer

    Figure 10. Other

    Figure 11. Global mRNA Vaccine Market Size 2015-2026 (US$ Million)

    Figure 12. Global mRNA Vaccine Sales Capacity (K Doses) (2015-2026)

    Figure 13. Global mRNA Vaccine Market Size Market Share by Region: 2020 Versus 2026

    Figure 14. mRNA Vaccine Sales Share by Manufacturers in 2020

    Figure 15. Global mRNA Vaccine Revenue Share by Manufacturers in 2019

    Figure 16. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine Revenue in 2019

    Figure 17. mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 18. Global mRNA Vaccine Sales Market Share by Region (2015-2020)

    Figure 19. Global mRNA Vaccine Sales Market Share by Region in 2019

    Figure 20. Global mRNA Vaccine Revenue Market Share by Region (2015-2020)

    Figure 21. Global mRNA Vaccine Revenue Market Share by Region in 2019

    Figure 22. North America mRNA Vaccine Sales Market Share by Country in 2019

    Figure 23. North America mRNA Vaccine Revenue Market Share by Country in 2019

    Figure 24. U.S. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 25. U.S. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 26. Canada mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 27. Canada mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 28. Europe mRNA Vaccine Sales Market Share by Country in 2019

    Figure 29. Europe mRNA Vaccine Revenue Market Share by Country in 2019

    Figure 30. Germany mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 31. Germany mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 32. France mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 33. France mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 34. U.K. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 35. U.K. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 36. Italy mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 37. Italy mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 38. Russia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 39. Russia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 40. Asia Pacific mRNA Vaccine Sales Market Share by Region in 2019

    Figure 41. Asia Pacific mRNA Vaccine Revenue Market Share by Region in 2019

    Figure 42. China mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 43. China mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 44. Japan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 45. Japan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 46. South Korea mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 47. South Korea mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 48. India mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 49. India mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 50. Australia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 51. Australia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 52. Taiwan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 53. Taiwan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 54. Indonesia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 55. Indonesia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 56. Thailand mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 57. Thailand mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 58. Malaysia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 59. Malaysia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 60. Philippines mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 61. Philippines mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 62. Vietnam mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 63. Vietnam mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 64. Latin America mRNA Vaccine Sales Market Share by Country in 2019

    Figure 65. Latin America mRNA Vaccine Revenue Market Share by Country in 2019

    Figure 66. Mexico mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 67. Mexico mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 68. Brazil mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 69. Brazil mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 70. Argentina mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 71. Argentina mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 72. Middle East and Africa mRNA Vaccine Sales Market Share by Country in 2019

    Figure 73. Middle East and Africa mRNA Vaccine Revenue Market Share by Country in 2019

    Figure 74. Turkey mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 75. Turkey mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 76. Saudi Arabia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 77. Saudi Arabia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 78. U.A.E mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

    Figure 79. U.A.E mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 80. Sales Market Share of mRNA Vaccine by Type (2015-2020)

    Figure 81. Sales Market Share of mRNA Vaccine by Type in 2019

    Figure 82. Revenue Share of mRNA Vaccine by Type (2015-2020)

    Figure 83. Revenue Market Share of mRNA Vaccine by Type in 2019

    Figure 84. Global mRNA Vaccine Sales Growth by Type (2015-2020) (K Doses)

    Figure 85. Global mRNA Vaccine Sales Market Share by Application (2015-2020)

    Figure 86. Global mRNA Vaccine Sales Market Share by Application in 2019

    Figure 87. Global Revenue Share of mRNA Vaccine by Application (2015-2020)

    Figure 88. Global Revenue Share of mRNA Vaccine by Application in 2020

    Figure 89. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 90. CureVac Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 91. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 92. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 93. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 94. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 95. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 96. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 97. Ethris Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 98. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 99. Price Trend of Key Raw Materials

    Figure 100. Manufacturing Cost Structure of mRNA Vaccine

    Figure 101. Manufacturing Process Analysis of mRNA Vaccine

    Figure 102. mRNA Vaccine Industrial Chain Analysis

    Figure 103. Channels of Distribution

    Figure 104. Distributors Profiles

    Figure 105. Porter's Five Forces Analysis

    Figure 106. North America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 107. North America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 108. Europe mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 109. Europe mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 110. Latin America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 111. Latin America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 112. Middle East and Africa mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 113. Middle East and Africa mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 114. Asia Pacific mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 115. Asia Pacific mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 116. Bottom-up and Top-down Approaches for This Report

    Figure 117. Data Triangulation

    Figure 118. Key Executives Interviewed